About Chronosome
Chronosome is a private company based in Los Angeles, California, incorporated in 2022 in Delaware. It has reported $60,000 raised in two offerings on Form D since February 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | May 29, 2025 | $0of $550K target | 0 | — | SAFERule 506(c) | Form D ↗ |
| Not yet | Feb 16, 2023 | $60,000of $500K target | 10 | $6,000 | EquityRule 504 | Form D ↗ |
| Total, two offerings | $60,000 | |||||
The filing for the offering first filed Feb 16, 2023 reports amount sold but first sale marked as not yet made. Figures are shown as filed.
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Chronosome's Form D filed May 29, 2025.
TC
Terry Curran
Executive officer
GM
Gordon Maniskas
Co-Founder/COO